BrainsWay

Break Free from Alcohol Use Disorder

Join a clinical research study evaluating Deep TMS® — a non-invasive treatment designed to help reduce heavy drinking and cravings.

No cost to participate. Compensation provided.
 
Please make sure you read all inclusion, exclusion, and time commitment criteria before you apply.

Trial Information

A New Option for Those Looking to Cut Back
Heavy alcohol use can take a toll on both your physical and mental health. Research shows that even reducing heavy drinking days for several months can lead to meaningful improvements in overall well-being.
 
BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS®) is being studied as a potential new tool to help people with Alcohol Use Disorder (AUD) reduce cravings and heavy drinking. This study will compare active Deep TMS® with a placebo-like (sham) treatment to evaluate its effectiveness.
 

Submit Your Information to Be Contacted by a Study Site

What to Expect

Study Participation in the Alcohol Use Disorder Clinical Trials Includes:
  • A screening visit to confirm eligibility
  • 36 total visits over approximately 6 months
  • About 15 visits during the first 3–5 weeks
  • Then one visit per week for about 5 months
  • Each visit includes either Deep TMS® or sham TMS plus educational sessions about alcohol use, coping skills, and behavioral change strategies
  • No cost to participate, and eligible participants will receive compensation for their time


About Deep TMS Technology

Brainsway Deep TMS is an innovative, non-invasive technology.

Deep TMS non-invasively stimulates the brain regions responsible for depression using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. The device has been cleared by the FDA for treating depression, obsessive compulsive disorder, and smoking addiction and has been studied in over 100 clinical trials around the world. The side effects are generally mild and can include headache or scalp discomfort at the treatment site. Since it does not involve medication, there are no systemic side effects, which is appealing for individuals who cannot tolerate drugs.

Who Can Join:

You may qualify if you:
  • Are 18–86 years old
  • Have a DSM-5 diagnosis of moderate to severe Alcohol Use Disorder
  • Have had 24 or more heavy drinking days in the past 90 days (5+ drinks/day for men, 4+ for women)
  • Are seeking treatment to reduce or stop heavy drinking
  • Can provide informed consent and comply with study procedures
  • Pass a standard TMS safety questionnaire

Who Can Not Join:

You may not qualify if you:
  • Started taking alcohol-affecting medications (e.g., naltrexone, disulfiram, gabapentin) within the past 30 days
  • Are experiencing acute alcohol withdrawal
  • Have metal implants in the head or neck
  • Have received TMS treatment within the past year
  • Are pregnant, nursing, or planning pregnancy

To learn more, contact one of our sites or visit the clinical trials page.

Study Locations

  • Alpha Neuron LLC – Tuscaloosa, AL 
  • DTMS Center LLC – West Palm Beach, FL  
  • Rosecrance River North – Chicago, IL  
  • ManuMind Interventional Psychiatry – Woodbury, NY
  • PsyCare – South Charleston, WV  
  • Soroka Medical Center - Beersheba, Israel 

BrainsWay Clinical Research

BrainsWay is a global leader in noninvasive neurostimulation technology, committed to advancing mental health care. Our FDA-cleared Deep TMS® treatment has helped people worldwide overcome depression, OCD, and smoking addiction. Through ongoing clinical research, we continue to expand access to safe, effective, and innovative mental health solutions.

How Does Deep TMS Work?

Deep Transcranial Magnetic Stimulation (Deep TMS®) uses magnetic pulses to safely and effectively stimulate specific brain regions related to mood, behavior, and addiction. Each session is brief, well-tolerated, and requires no downtime. This noninvasive treatment is designed to help restore healthy brain activity and support long-term recovery.

Explore Treatment Options

Deep TMS® is FDA-cleared for Major Depressive Disorder, Obsessive-Compulsive Disorder, Anxious Depression, Late-Life Depression, Smoking Addiction, and is being studied for Alcohol Use Disorder and other conditions. Discover how Deep TMS® is improving quality of life and transforming the way clinicians approach mental health treatment worldwide.

BrainsWay and the BrainsWay logo are trademarks of BrainsWay Ltd. © 2025 BrainsWay. All Rights Reserved.